

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 8.40885049 |
| 2 | muscle organ morphogenesis (GO:0048644) | 6.88499886 |
| 3 | ear development (GO:0043583) | 6.45041131 |
| 4 | regulation of somitogenesis (GO:0014807) | 6.39279492 |
| 5 | embryonic heart tube development (GO:0035050) | 6.07464890 |
| 6 | positive regulation of gastrulation (GO:2000543) | 5.53432254 |
| 7 | regulation of glucokinase activity (GO:0033131) | 5.11822715 |
| 8 | regulation of hexokinase activity (GO:1903299) | 5.11822715 |
| 9 | organelle membrane fusion (GO:0090174) | 5.03328703 |
| 10 | neuromuscular process controlling posture (GO:0050884) | 4.80308491 |
| 11 | positive regulation of vesicle fusion (GO:0031340) | 4.67098300 |
| 12 | magnesium ion transport (GO:0015693) | 4.66319420 |
| 13 | autophagic vacuole fusion (GO:0000046) | 4.65454365 |
| 14 | lymphangiogenesis (GO:0001946) | 4.64646087 |
| 15 | mesenchymal to epithelial transition (GO:0060231) | 4.59531475 |
| 16 | positive regulation of embryonic development (GO:0040019) | 4.53530504 |
| 17 | pyrimidine dimer repair (GO:0006290) | 4.38249336 |
| 18 | cysteine metabolic process (GO:0006534) | 4.35819392 |
| 19 | regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358) | 4.32401675 |
| 20 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 4.25955918 |
| 21 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 4.25014891 |
| 22 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 4.14457245 |
| 23 | nitric oxide mediated signal transduction (GO:0007263) | 4.12058136 |
| 24 | endocardial cushion development (GO:0003197) | 4.10859495 |
| 25 | nucleoside diphosphate phosphorylation (GO:0006165) | 4.08087168 |
| 26 | regulation of stem cell maintenance (GO:2000036) | 4.07263824 |
| 27 | paraxial mesoderm development (GO:0048339) | 4.05830032 |
| 28 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 4.01767664 |
| 29 | peptide catabolic process (GO:0043171) | 3.99958184 |
| 30 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:004316 | 3.96935779 |
| 31 | nephron tubule formation (GO:0072079) | 3.91455326 |
| 32 | positive regulation of prostaglandin secretion (GO:0032308) | 3.89360077 |
| 33 | establishment of endothelial barrier (GO:0061028) | 3.82219047 |
| 34 | axoneme assembly (GO:0035082) | 3.80765168 |
| 35 | establishment of apical/basal cell polarity (GO:0035089) | 3.72861768 |
| 36 | pattern specification involved in kidney development (GO:0061004) | 3.68933592 |
| 37 | protein K11-linked deubiquitination (GO:0035871) | 3.66510285 |
| 38 | neural tube formation (GO:0001841) | 3.60619169 |
| 39 | ventricular system development (GO:0021591) | 3.59549904 |
| 40 | lens fiber cell development (GO:0070307) | 3.56377856 |
| 41 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 3.54371445 |
| 42 | prenylation (GO:0097354) | 3.53132040 |
| 43 | protein prenylation (GO:0018342) | 3.53132040 |
| 44 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 3.52157903 |
| 45 | cardiovascular system development (GO:0072358) | 3.51134768 |
| 46 | positive regulation of icosanoid secretion (GO:0032305) | 3.49986015 |
| 47 | positive regulation of fatty acid transport (GO:2000193) | 3.48866067 |
| 48 | endoderm formation (GO:0001706) | 3.41175176 |
| 49 | mRNA transcription from RNA polymerase II promoter (GO:0042789) | 3.40259163 |
| 50 | dopaminergic neuron differentiation (GO:0071542) | 3.37686198 |
| 51 | establishment of monopolar cell polarity (GO:0061162) | 3.37440400 |
| 52 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 3.37440400 |
| 53 | regulation of mesenchymal cell apoptotic process (GO:2001053) | 3.33794835 |
| 54 | negative regulation of mast cell activation (GO:0033004) | 3.33332240 |
| 55 | polarized epithelial cell differentiation (GO:0030859) | 3.26877301 |
| 56 | signal transduction involved in regulation of gene expression (GO:0023019) | 3.20260997 |
| 57 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.18668873 |
| 58 | mRNA transcription (GO:0009299) | 3.16863983 |
| 59 | ubiquinone biosynthetic process (GO:0006744) | 3.16721637 |
| 60 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.16273483 |
| 61 | regulation of prostaglandin secretion (GO:0032306) | 3.15078906 |
| 62 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 3.14810974 |
| 63 | ventricular septum development (GO:0003281) | 3.14016783 |
| 64 | positive regulation of fatty acid oxidation (GO:0046321) | 3.11942244 |
| 65 | multicellular organism reproduction (GO:0032504) | 3.08720427 |
| 66 | ubiquinone metabolic process (GO:0006743) | 3.02405907 |
| 67 | regulation of establishment of cell polarity (GO:2000114) | 3.00274570 |
| 68 | serine family amino acid biosynthetic process (GO:0009070) | 2.99884264 |
| 69 | embryonic epithelial tube formation (GO:0001838) | 2.98618561 |
| 70 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 2.97277342 |
| 71 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.92590228 |
| 72 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.91712393 |
| 73 | eating behavior (GO:0042755) | 2.87159067 |
| 74 | regulation of respiratory system process (GO:0044065) | 2.86399367 |
| 75 | epithelial tube formation (GO:0072175) | 2.84645523 |
| 76 | RNA destabilization (GO:0050779) | 2.79966177 |
| 77 | endothelial cell development (GO:0001885) | 2.76153187 |
| 78 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.74025415 |
| 79 | mesonephros development (GO:0001823) | 2.73890425 |
| 80 | hyperosmotic salinity response (GO:0042538) | 2.72583415 |
| 81 | protein-cofactor linkage (GO:0018065) | 2.70646232 |
| 82 | establishment of epithelial cell polarity (GO:0090162) | 2.70078846 |
| 83 | interferon-gamma secretion (GO:0072643) | 2.68095104 |
| 84 | acrosome assembly (GO:0001675) | 2.66122032 |
| 85 | primary amino compound metabolic process (GO:1901160) | 2.65740185 |
| 86 | parturition (GO:0007567) | 2.64912578 |
| 87 | alanine transport (GO:0032328) | 2.64614674 |
| 88 | regulation of fatty acid oxidation (GO:0046320) | 2.63279445 |
| 89 | nodal signaling pathway (GO:0038092) | 2.61506031 |
| 90 | positive regulation by host of viral transcription (GO:0043923) | 2.61200725 |
| 91 | lymph node development (GO:0048535) | 2.59945784 |
| 92 | regulation of organ formation (GO:0003156) | 2.59830246 |
| 93 | piRNA metabolic process (GO:0034587) | 2.58618368 |
| 94 | ovulation from ovarian follicle (GO:0001542) | 2.57665491 |
| 95 | regulation of gastrulation (GO:0010470) | 2.57086036 |
| 96 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.56560899 |
| 97 | type B pancreatic cell development (GO:0003323) | 2.54130954 |
| 98 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 2.51469509 |
| 99 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.50885105 |
| 100 | neuronal action potential (GO:0019228) | 2.50649961 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 6.15120571 |
| 2 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.79492923 |
| 3 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 4.34315478 |
| 4 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 4.34315478 |
| 5 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 4.34315478 |
| 6 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.21689897 |
| 7 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 3.09605955 |
| 8 | VDR_22108803_ChIP-Seq_LS180_Human | 2.99849589 |
| 9 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.80207333 |
| 10 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.42136672 |
| 11 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.05973219 |
| 12 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.02445182 |
| 13 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.90208687 |
| 14 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.79258710 |
| 15 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.78808472 |
| 16 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.76627148 |
| 17 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.72000808 |
| 18 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.69591614 |
| 19 | P300_19829295_ChIP-Seq_ESCs_Human | 1.66749938 |
| 20 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.64693592 |
| 21 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.56678770 |
| 22 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.56434696 |
| 23 | TP53_16413492_ChIP-PET_HCT116_Human | 1.53141144 |
| 24 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.51358447 |
| 25 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.48929833 |
| 26 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.42912895 |
| 27 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.42801622 |
| 28 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.38382514 |
| 29 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.37596421 |
| 30 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.37596421 |
| 31 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.36705777 |
| 32 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.35418142 |
| 33 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.35358928 |
| 34 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.35282402 |
| 35 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.30977137 |
| 36 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.29949055 |
| 37 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.27088396 |
| 38 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.26950991 |
| 39 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.25933110 |
| 40 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.25228113 |
| 41 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.25194258 |
| 42 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.25180523 |
| 43 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.24930422 |
| 44 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.24506289 |
| 45 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.24143075 |
| 46 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.23778757 |
| 47 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.21629315 |
| 48 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21512227 |
| 49 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.21512227 |
| 50 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.21493975 |
| 51 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.21149309 |
| 52 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.19278060 |
| 53 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.18788141 |
| 54 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.16454364 |
| 55 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.16063304 |
| 56 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.16009813 |
| 57 | EWS_26573619_Chip-Seq_HEK293_Human | 1.15838171 |
| 58 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.15823613 |
| 59 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.15771091 |
| 60 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15246706 |
| 61 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.14691863 |
| 62 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.14592566 |
| 63 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.14388062 |
| 64 | AR_25329375_ChIP-Seq_VCAP_Human | 1.10598281 |
| 65 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.09284417 |
| 66 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.09259253 |
| 67 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.08818382 |
| 68 | ERA_21632823_ChIP-Seq_H3396_Human | 1.08809258 |
| 69 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.07496497 |
| 70 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.05495666 |
| 71 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.04699163 |
| 72 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.04107706 |
| 73 | TCF4_23295773_ChIP-Seq_U87_Human | 1.03116420 |
| 74 | FUS_26573619_Chip-Seq_HEK293_Human | 1.03013813 |
| 75 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.02570608 |
| 76 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.02562266 |
| 77 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 1.01358617 |
| 78 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.01262340 |
| 79 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.01240636 |
| 80 | STAT3_23295773_ChIP-Seq_U87_Human | 0.98786908 |
| 81 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96324041 |
| 82 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.95602894 |
| 83 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.95057327 |
| 84 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.94842002 |
| 85 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.94364812 |
| 86 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.93087372 |
| 87 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.92563926 |
| 88 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.92411960 |
| 89 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.92230761 |
| 90 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.92155097 |
| 91 | GF1B_26923725_Chip-Seq_HPCs_Mouse | 0.91392861 |
| 92 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.91080560 |
| 93 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.90965951 |
| 94 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.90470544 |
| 95 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.89726219 |
| 96 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.89188074 |
| 97 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.89088088 |
| 98 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.88494658 |
| 99 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.86257259 |
| 100 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.86257259 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000372_irregular_coat_pigmentation | 6.00606899 |
| 2 | MP0010386_abnormal_urinary_bladder | 4.07387571 |
| 3 | MP0003183_abnormal_peptide_metabolism | 4.01158433 |
| 4 | MP0002277_abnormal_respiratory_mucosa | 3.94184640 |
| 5 | MP0003941_abnormal_skin_development | 3.83536467 |
| 6 | MP0006054_spinal_hemorrhage | 3.44857516 |
| 7 | MP0003136_yellow_coat_color | 3.27938552 |
| 8 | MP0001879_abnormal_lymphatic_vessel | 3.01803087 |
| 9 | MP0002089_abnormal_postnatal_growth/wei | 2.85127869 |
| 10 | MP0004133_heterotaxia | 2.71309189 |
| 11 | MP0010030_abnormal_orbit_morphology | 2.45737868 |
| 12 | MP0005409_darkened_coat_color | 2.42611091 |
| 13 | MP0002876_abnormal_thyroid_physiology | 2.28911563 |
| 14 | MP0001299_abnormal_eye_distance/ | 2.12786446 |
| 15 | MP0001502_abnormal_circadian_rhythm | 2.10281783 |
| 16 | MP0005257_abnormal_intraocular_pressure | 2.05478891 |
| 17 | MP0002160_abnormal_reproductive_system | 2.05339208 |
| 18 | MP0001346_abnormal_lacrimal_gland | 2.05214799 |
| 19 | MP0005503_abnormal_tendon_morphology | 1.95983708 |
| 20 | MP0009384_cardiac_valve_regurgitation | 1.91127147 |
| 21 | MP0008995_early_reproductive_senescence | 1.84612570 |
| 22 | MP0004043_abnormal_pH_regulation | 1.83470498 |
| 23 | MP0002177_abnormal_outer_ear | 1.71086223 |
| 24 | MP0000733_abnormal_muscle_development | 1.69224510 |
| 25 | MP0002638_abnormal_pupillary_reflex | 1.54945391 |
| 26 | MP0002138_abnormal_hepatobiliary_system | 1.51662455 |
| 27 | MP0005389_reproductive_system_phenotype | 1.46812294 |
| 28 | MP0002928_abnormal_bile_duct | 1.44376618 |
| 29 | MP0005083_abnormal_biliary_tract | 1.42060702 |
| 30 | MP0003879_abnormal_hair_cell | 1.41065903 |
| 31 | MP0003937_abnormal_limbs/digits/tail_de | 1.38547857 |
| 32 | MP0002396_abnormal_hematopoietic_system | 1.37575580 |
| 33 | MP0008877_abnormal_DNA_methylation | 1.36075682 |
| 34 | MP0003195_calcinosis | 1.26720075 |
| 35 | MP0009250_abnormal_appendicular_skeleto | 1.24444813 |
| 36 | MP0008875_abnormal_xenobiotic_pharmacok | 1.24434762 |
| 37 | MP0002282_abnormal_trachea_morphology | 1.22570651 |
| 38 | MP0005646_abnormal_pituitary_gland | 1.21777113 |
| 39 | MP0005084_abnormal_gallbladder_morpholo | 1.21662561 |
| 40 | MP0005187_abnormal_penis_morphology | 1.21242851 |
| 41 | MP0002098_abnormal_vibrissa_morphology | 1.19663876 |
| 42 | MP0010352_gastrointestinal_tract_polyps | 1.16432966 |
| 43 | MP0000631_abnormal_neuroendocrine_gland | 1.15812335 |
| 44 | MP0003252_abnormal_bile_duct | 1.14546891 |
| 45 | MP0002075_abnormal_coat/hair_pigmentati | 1.14351972 |
| 46 | MP0008789_abnormal_olfactory_epithelium | 1.14351708 |
| 47 | MP0003938_abnormal_ear_development | 1.14039656 |
| 48 | MP0005085_abnormal_gallbladder_physiolo | 1.12645133 |
| 49 | MP0001485_abnormal_pinna_reflex | 1.11067180 |
| 50 | MP0002735_abnormal_chemical_nociception | 1.06230958 |
| 51 | MP0002009_preneoplasia | 1.05904174 |
| 52 | MP0003950_abnormal_plasma_membrane | 1.05480150 |
| 53 | MP0009046_muscle_twitch | 1.01989576 |
| 54 | MP0005394_taste/olfaction_phenotype | 1.01833087 |
| 55 | MP0005499_abnormal_olfactory_system | 1.01833087 |
| 56 | MP0003646_muscle_fatigue | 1.00870053 |
| 57 | MP0002736_abnormal_nociception_after | 1.00217593 |
| 58 | MP0000371_diluted_coat_color | 0.98902559 |
| 59 | MP0004019_abnormal_vitamin_homeostasis | 0.91317272 |
| 60 | MP0005197_abnormal_uvea_morphology | 0.89066830 |
| 61 | MP0005508_abnormal_skeleton_morphology | 0.87987632 |
| 62 | MP0001905_abnormal_dopamine_level | 0.86858676 |
| 63 | MP0002127_abnormal_cardiovascular_syste | 0.85853706 |
| 64 | MP0008961_abnormal_basal_metabolism | 0.84765604 |
| 65 | MP0001919_abnormal_reproductive_system | 0.84639116 |
| 66 | MP0005647_abnormal_sex_gland | 0.83894118 |
| 67 | MP0001186_pigmentation_phenotype | 0.83462249 |
| 68 | MP0008872_abnormal_physiological_respon | 0.83201540 |
| 69 | MP0001968_abnormal_touch/_nociception | 0.83100610 |
| 70 | MP0002111_abnormal_tail_morphology | 0.82582744 |
| 71 | MP0005645_abnormal_hypothalamus_physiol | 0.81918025 |
| 72 | MP0000685_abnormal_immune_system | 0.81883203 |
| 73 | MP0005410_abnormal_fertilization | 0.81119478 |
| 74 | MP0000534_abnormal_ureter_morphology | 0.79925582 |
| 75 | MP0002909_abnormal_adrenal_gland | 0.79524402 |
| 76 | MP0002733_abnormal_thermal_nociception | 0.79110020 |
| 77 | MP0002734_abnormal_mechanical_nocicepti | 0.78666637 |
| 78 | MP0001270_distended_abdomen | 0.75407041 |
| 79 | MP0003936_abnormal_reproductive_system | 0.73179793 |
| 80 | MP0002233_abnormal_nose_morphology | 0.72550385 |
| 81 | MP0001324_abnormal_eye_pigmentation | 0.71835211 |
| 82 | MP0003633_abnormal_nervous_system | 0.71580844 |
| 83 | MP0000613_abnormal_salivary_gland | 0.71305775 |
| 84 | MP0002116_abnormal_craniofacial_bone | 0.70998358 |
| 85 | MP0000003_abnormal_adipose_tissue | 0.70484557 |
| 86 | MP0005551_abnormal_eye_electrophysiolog | 0.70417992 |
| 87 | MP0005171_absent_coat_pigmentation | 0.67839461 |
| 88 | MP0000049_abnormal_middle_ear | 0.65266542 |
| 89 | MP0003942_abnormal_urinary_system | 0.64329514 |
| 90 | MP0008775_abnormal_heart_ventricle | 0.62897327 |
| 91 | MP0003718_maternal_effect | 0.60248035 |
| 92 | MP0003045_fibrosis | 0.58967046 |
| 93 | MP0000428_abnormal_craniofacial_morphol | 0.58907379 |
| 94 | MP0000762_abnormal_tongue_morphology | 0.57845294 |
| 95 | MP0001881_abnormal_mammary_gland | 0.56714687 |
| 96 | MP0009745_abnormal_behavioral_response | 0.56561069 |
| 97 | MP0002272_abnormal_nervous_system | 0.55976384 |
| 98 | MP0002249_abnormal_larynx_morphology | 0.55725691 |
| 99 | MP0000639_abnormal_adrenal_gland | 0.54332304 |
| 100 | MP0000230_abnormal_systemic_arterial | 0.53944165 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoplastic ischia (HP:0003175) | 5.43353705 |
| 2 | Fibular aplasia (HP:0002990) | 5.14351909 |
| 3 | Bell-shaped thorax (HP:0001591) | 5.13459916 |
| 4 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 4.96526842 |
| 5 | Abnormality of the ischium (HP:0003174) | 4.83493561 |
| 6 | Mesomelia (HP:0003027) | 4.65098344 |
| 7 | Hypomagnesemia (HP:0002917) | 4.61926811 |
| 8 | Tetany (HP:0001281) | 4.55822584 |
| 9 | Abnormal drinking behavior (HP:0030082) | 4.41197720 |
| 10 | Polydipsia (HP:0001959) | 4.41197720 |
| 11 | 2-3 toe syndactyly (HP:0004691) | 4.27291803 |
| 12 | Nonimmune hydrops fetalis (HP:0001790) | 4.26851349 |
| 13 | Long clavicles (HP:0000890) | 4.20081339 |
| 14 | Wrist flexion contracture (HP:0001239) | 4.10162982 |
| 15 | Stomach cancer (HP:0012126) | 3.74193243 |
| 16 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.67856675 |
| 17 | Abnormality of magnesium homeostasis (HP:0004921) | 3.64790423 |
| 18 | Abnormality of the pubic bones (HP:0003172) | 3.63960188 |
| 19 | Lymphangioma (HP:0100764) | 3.59212558 |
| 20 | Type I diabetes mellitus (HP:0100651) | 3.48105879 |
| 21 | Abnormal finger flexion creases (HP:0006143) | 3.17964484 |
| 22 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 3.10751753 |
| 23 | Absent eyebrow (HP:0002223) | 3.03429158 |
| 24 | Cutaneous finger syndactyly (HP:0010554) | 2.99956385 |
| 25 | Nonprogressive disorder (HP:0003680) | 2.94887649 |
| 26 | Absent phalangeal crease (HP:0006109) | 2.93881881 |
| 27 | Abnormality of the columella (HP:0009929) | 2.93544858 |
| 28 | Aplasia/Hypoplasia of the earlobes (HP:0009906) | 2.93463695 |
| 29 | Birth length less than 3rd percentile (HP:0003561) | 2.69340012 |
| 30 | Polyuria (HP:0000103) | 2.68014745 |
| 31 | Pancreatic fibrosis (HP:0100732) | 2.67373515 |
| 32 | Pendular nystagmus (HP:0012043) | 2.63070436 |
| 33 | Split foot (HP:0001839) | 2.61056734 |
| 34 | Anencephaly (HP:0002323) | 2.54968252 |
| 35 | Microglossia (HP:0000171) | 2.53854641 |
| 36 | Hypothermia (HP:0002045) | 2.52857386 |
| 37 | Hypoplastic iliac wings (HP:0002866) | 2.52468339 |
| 38 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.51814004 |
| 39 | Microtia (HP:0008551) | 2.51096111 |
| 40 | Thyroid-stimulating hormone excess (HP:0002925) | 2.49885571 |
| 41 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.49322808 |
| 42 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.49322808 |
| 43 | Cupped ear (HP:0000378) | 2.48169225 |
| 44 | Decreased central vision (HP:0007663) | 2.48025466 |
| 45 | Alveolar cell carcinoma (HP:0006519) | 2.47393121 |
| 46 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 2.44839999 |
| 47 | Gaze-evoked nystagmus (HP:0000640) | 2.43123839 |
| 48 | Venous insufficiency (HP:0005293) | 2.42951886 |
| 49 | Late onset (HP:0003584) | 2.38348829 |
| 50 | Tubular atrophy (HP:0000092) | 2.34274724 |
| 51 | Renal tubular acidosis (HP:0001947) | 2.31562345 |
| 52 | Cutaneous syndactyly (HP:0012725) | 2.30373464 |
| 53 | Absent hair (HP:0002298) | 2.26601474 |
| 54 | Pancreatic cysts (HP:0001737) | 2.21629522 |
| 55 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.20134273 |
| 56 | Abnormality of alanine metabolism (HP:0010916) | 2.20134273 |
| 57 | Hyperalaninemia (HP:0003348) | 2.20134273 |
| 58 | Spinal muscular atrophy (HP:0007269) | 2.20018145 |
| 59 | Aplasia of the musculature (HP:0100854) | 2.18457737 |
| 60 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.17360759 |
| 61 | Cleft eyelid (HP:0000625) | 2.15086778 |
| 62 | Abnormal urine output (HP:0012590) | 2.15082489 |
| 63 | Aplasia/Hypoplasia of the scapulae (HP:0006713) | 2.13772055 |
| 64 | Hypoplastic scapulae (HP:0000882) | 2.13772055 |
| 65 | Barrel-shaped chest (HP:0001552) | 2.13617297 |
| 66 | True hermaphroditism (HP:0010459) | 2.12552902 |
| 67 | Diastasis recti (HP:0001540) | 2.11701506 |
| 68 | Breast aplasia (HP:0100783) | 2.10860762 |
| 69 | Palpebral edema (HP:0100540) | 2.10451388 |
| 70 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.06288846 |
| 71 | Depressed nasal tip (HP:0000437) | 2.05165044 |
| 72 | Anhidrosis (HP:0000970) | 2.04904784 |
| 73 | Concave nail (HP:0001598) | 2.01489619 |
| 74 | Conical tooth (HP:0000698) | 2.00050128 |
| 75 | Facial edema (HP:0000282) | 1.95147836 |
| 76 | Absent eyelashes (HP:0000561) | 1.95110306 |
| 77 | Periorbital edema (HP:0100539) | 1.94927654 |
| 78 | Rhinitis (HP:0012384) | 1.93390691 |
| 79 | Abnormality of renal excretion (HP:0011036) | 1.93272464 |
| 80 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.92316771 |
| 81 | Increased corneal curvature (HP:0100692) | 1.91686454 |
| 82 | Keratoconus (HP:0000563) | 1.91686454 |
| 83 | Congenital hepatic fibrosis (HP:0002612) | 1.89513399 |
| 84 | Chronic bronchitis (HP:0004469) | 1.86569128 |
| 85 | Hypercalciuria (HP:0002150) | 1.85959655 |
| 86 | Adactyly (HP:0009776) | 1.85268417 |
| 87 | Hyperuricemia (HP:0002149) | 1.85203879 |
| 88 | Increased purine levels (HP:0004368) | 1.85203879 |
| 89 | Subacute progressive viral hepatitis (HP:0006572) | 1.84190307 |
| 90 | Nephritis (HP:0000123) | 1.81245971 |
| 91 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.80794895 |
| 92 | Aplasia/Hypoplasia involving the pelvis (HP:0009103) | 1.80264904 |
| 93 | Patellar aplasia (HP:0006443) | 1.79500681 |
| 94 | Aplasia/Hypoplasia of the nipples (HP:0006709) | 1.78607361 |
| 95 | Prominent supraorbital ridges (HP:0000336) | 1.77360755 |
| 96 | Hyperthyroidism (HP:0000836) | 1.76946369 |
| 97 | Aplasia/Hypoplasia of the breasts (HP:0010311) | 1.76280377 |
| 98 | Furrowed tongue (HP:0000221) | 1.76186632 |
| 99 | Hypotrichosis (HP:0001006) | 1.75428387 |
| 100 | Abnormality of the antihelix (HP:0009738) | 1.75174634 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PDK2 | 5.17713759 |
| 2 | TAOK3 | 4.76602657 |
| 3 | MAP3K10 | 4.38718057 |
| 4 | MAP2K7 | 3.72695200 |
| 5 | PNCK | 3.40616739 |
| 6 | FRK | 3.03046897 |
| 7 | PINK1 | 3.02128095 |
| 8 | INSRR | 2.96675593 |
| 9 | BRSK2 | 2.70015222 |
| 10 | STK24 | 2.29044669 |
| 11 | NUAK1 | 2.20094818 |
| 12 | MKNK2 | 2.11402027 |
| 13 | CSF1R | 1.72846135 |
| 14 | CCNB1 | 1.67710627 |
| 15 | MAPK15 | 1.59671803 |
| 16 | IRAK1 | 1.53513308 |
| 17 | LIMK1 | 1.51361281 |
| 18 | WNK3 | 1.51167238 |
| 19 | PAK3 | 1.41728291 |
| 20 | STK3 | 1.36911519 |
| 21 | ADRBK2 | 1.30951067 |
| 22 | NEK6 | 1.28115591 |
| 23 | MAPKAPK3 | 1.28055709 |
| 24 | NEK9 | 1.25384975 |
| 25 | NEK2 | 1.24464443 |
| 26 | ACVR1B | 1.21937443 |
| 27 | BMPR1B | 1.21383995 |
| 28 | PKN2 | 1.21264468 |
| 29 | DMPK | 1.18721616 |
| 30 | GRK1 | 1.16468583 |
| 31 | TLK1 | 1.11813849 |
| 32 | RPS6KA4 | 1.07561283 |
| 33 | MAP4K2 | 1.05919071 |
| 34 | MKNK1 | 1.01600437 |
| 35 | MAP3K14 | 0.98184265 |
| 36 | TAOK1 | 0.92968807 |
| 37 | RPS6KB2 | 0.82639437 |
| 38 | PDK1 | 0.81756020 |
| 39 | ADRBK1 | 0.80742249 |
| 40 | MELK | 0.78646440 |
| 41 | PRKCI | 0.77864806 |
| 42 | IKBKE | 0.77557216 |
| 43 | MUSK | 0.77029650 |
| 44 | WNK4 | 0.75068503 |
| 45 | PRKCG | 0.74863353 |
| 46 | PRKCQ | 0.72089927 |
| 47 | PDPK1 | 0.71122867 |
| 48 | MARK3 | 0.70860198 |
| 49 | PKN1 | 0.70793820 |
| 50 | MAPK12 | 0.70232168 |
| 51 | CHUK | 0.67315510 |
| 52 | MAP3K5 | 0.64537861 |
| 53 | ZAK | 0.63641568 |
| 54 | WEE1 | 0.63599878 |
| 55 | PLK3 | 0.62340058 |
| 56 | IKBKB | 0.61452537 |
| 57 | TGFBR1 | 0.59312871 |
| 58 | PTK6 | 0.59022612 |
| 59 | TEC | 0.58854079 |
| 60 | CSNK1A1 | 0.58728001 |
| 61 | PRKAA2 | 0.58316921 |
| 62 | MAP3K13 | 0.55569559 |
| 63 | PTK2B | 0.55443456 |
| 64 | MAP3K4 | 0.54622400 |
| 65 | PLK2 | 0.54240908 |
| 66 | PLK1 | 0.52443374 |
| 67 | CDK3 | 0.51940635 |
| 68 | CAMK2A | 0.50908920 |
| 69 | CHEK2 | 0.48863786 |
| 70 | TBK1 | 0.48062787 |
| 71 | BRSK1 | 0.47116467 |
| 72 | EIF2AK2 | 0.47099614 |
| 73 | TTK | 0.45134340 |
| 74 | DYRK1A | 0.43640018 |
| 75 | AKT3 | 0.40535679 |
| 76 | TIE1 | 0.40094316 |
| 77 | GSK3A | 0.39003307 |
| 78 | PRKCE | 0.38676167 |
| 79 | SGK1 | 0.38002228 |
| 80 | STK39 | 0.37532908 |
| 81 | CAMK1G | 0.37502319 |
| 82 | STK38L | 0.36978991 |
| 83 | IGF1R | 0.35461876 |
| 84 | EIF2AK3 | 0.35440700 |
| 85 | CDC7 | 0.35268211 |
| 86 | PIM1 | 0.34712490 |
| 87 | MAP3K3 | 0.34360284 |
| 88 | PIK3CA | 0.33022228 |
| 89 | MAPK13 | 0.30708265 |
| 90 | CAMK1 | 0.30550345 |
| 91 | IRAK4 | 0.30491460 |
| 92 | MET | 0.29578741 |
| 93 | TESK1 | 0.27947787 |
| 94 | ILK | 0.27002368 |
| 95 | RPS6KB1 | 0.26732414 |
| 96 | FGFR1 | 0.26318044 |
| 97 | TRIB3 | 0.25911878 |
| 98 | FGFR2 | 0.25745772 |
| 99 | DYRK3 | 0.25528990 |
| 100 | MYLK | 0.24428447 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 6.11152397 |
| 2 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 5.22919841 |
| 3 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 3.32726955 |
| 4 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.39714086 |
| 5 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.16535759 |
| 6 | Sulfur relay system_Homo sapiens_hsa04122 | 2.07102165 |
| 7 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.05134987 |
| 8 | Basal transcription factors_Homo sapiens_hsa03022 | 2.01984990 |
| 9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.98082886 |
| 10 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.95548734 |
| 11 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.77303152 |
| 12 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.75945437 |
| 13 | Phototransduction_Homo sapiens_hsa04744 | 1.65350709 |
| 14 | Circadian entrainment_Homo sapiens_hsa04713 | 1.60562485 |
| 15 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.55618019 |
| 16 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.52435034 |
| 17 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.42871367 |
| 18 | Homologous recombination_Homo sapiens_hsa03440 | 1.41841828 |
| 19 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.36698442 |
| 20 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.34038725 |
| 21 | Taste transduction_Homo sapiens_hsa04742 | 1.31487877 |
| 22 | Salivary secretion_Homo sapiens_hsa04970 | 1.29510536 |
| 23 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.28470944 |
| 24 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.26079457 |
| 25 | ABC transporters_Homo sapiens_hsa02010 | 1.25952672 |
| 26 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.25615401 |
| 27 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.24479625 |
| 28 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.20177751 |
| 29 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.19969129 |
| 30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.17795977 |
| 31 | Nicotine addiction_Homo sapiens_hsa05033 | 1.16623511 |
| 32 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.15709124 |
| 33 | Tight junction_Homo sapiens_hsa04530 | 1.11872314 |
| 34 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.09979550 |
| 35 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.09748537 |
| 36 | Hepatitis C_Homo sapiens_hsa05160 | 1.08913164 |
| 37 | Other glycan degradation_Homo sapiens_hsa00511 | 1.05292115 |
| 38 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.01380663 |
| 39 | Olfactory transduction_Homo sapiens_hsa04740 | 0.99301966 |
| 40 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.98584472 |
| 41 | Histidine metabolism_Homo sapiens_hsa00340 | 0.95690734 |
| 42 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.94938871 |
| 43 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.94347544 |
| 44 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.94073584 |
| 45 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.93681588 |
| 46 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.89229061 |
| 47 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.88045350 |
| 48 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.87649741 |
| 49 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.87059223 |
| 50 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.86766085 |
| 51 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.86561125 |
| 52 | Protein export_Homo sapiens_hsa03060 | 0.83753789 |
| 53 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.83262167 |
| 54 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.81270693 |
| 55 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.80000750 |
| 56 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.78564027 |
| 57 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.74238044 |
| 58 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.69390111 |
| 59 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.66886902 |
| 60 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.66225959 |
| 61 | Cocaine addiction_Homo sapiens_hsa05030 | 0.66189976 |
| 62 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.66131178 |
| 63 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.62987560 |
| 64 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.62370571 |
| 65 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.62004936 |
| 66 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.61442617 |
| 67 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.61208372 |
| 68 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.60575988 |
| 69 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.60514836 |
| 70 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.60417644 |
| 71 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.57779873 |
| 72 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.56450163 |
| 73 | Circadian rhythm_Homo sapiens_hsa04710 | 0.56412105 |
| 74 | Galactose metabolism_Homo sapiens_hsa00052 | 0.55517525 |
| 75 | Morphine addiction_Homo sapiens_hsa05032 | 0.54866253 |
| 76 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.54813093 |
| 77 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.53850327 |
| 78 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.52947010 |
| 79 | Long-term depression_Homo sapiens_hsa04730 | 0.52468380 |
| 80 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.50373582 |
| 81 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.48524464 |
| 82 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.48248000 |
| 83 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.46479407 |
| 84 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.46035319 |
| 85 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.44715107 |
| 86 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.42715250 |
| 87 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.42562818 |
| 88 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.40914584 |
| 89 | Purine metabolism_Homo sapiens_hsa00230 | 0.40357155 |
| 90 | RNA polymerase_Homo sapiens_hsa03020 | 0.39876654 |
| 91 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.38026274 |
| 92 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.36962794 |
| 93 | Mineral absorption_Homo sapiens_hsa04978 | 0.36355920 |
| 94 | Metabolic pathways_Homo sapiens_hsa01100 | 0.35205865 |
| 95 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.34699471 |
| 96 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.34291842 |
| 97 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.33138742 |
| 98 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.32943791 |
| 99 | Huntingtons disease_Homo sapiens_hsa05016 | 0.32904936 |
| 100 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.32601437 |

